These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 3013645

  • 1. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
    Kehrl JH, Grove JH, Goldsmith PK, Fauci AS.
    Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
    [Abstract] [Full Text] [Related]

  • 2. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S, Giudizi GM, Maggi E, Almerigogna F, Biagiotti R, Del Prete G, Mazzetti M, Alessi A, Vercelli D, Ricci M.
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [Abstract] [Full Text] [Related]

  • 3. Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor.
    Ambrus JL, Chesky L, Stephany D, McFarland P, Mostowski H, Fauci AS.
    J Immunol; 1990 Dec 15; 145(12):3949-55. PubMed ID: 2258603
    [Abstract] [Full Text] [Related]

  • 4. Evidence for an association between CD23 and the receptor for a low molecular weight B cell growth factor.
    Gordon J, Webb AJ, Walker L, Guy GR, Rowe M.
    Eur J Immunol; 1986 Dec 15; 16(12):1627-30. PubMed ID: 3028819
    [Abstract] [Full Text] [Related]

  • 5. Demonstration that human B cells respond differently to interleukin 2 and B cell differentiation factor based on their stages of maturation.
    Nakagawa T, Nakagawa N, Goldstein H, Volkman DJ, Fauci AS.
    J Immunol; 1986 Nov 15; 137(10):3175-82. PubMed ID: 2945860
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of interleukin 2 vs B cell growth factor on human B cells.
    Nakagawa T, Nakagawa N, Ambrus JL, Fauci AS.
    J Immunol; 1988 Jan 15; 140(2):465-9. PubMed ID: 2447179
    [Abstract] [Full Text] [Related]

  • 7. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
    Sherris D, Stohl W, Mayer L.
    J Immunol; 1989 Apr 01; 142(7):2343-51. PubMed ID: 2538506
    [Abstract] [Full Text] [Related]

  • 8. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF).
    Vazquez A, Gérard JP, Olive D, Auffredou MT, Dugas B, Karray S, Delfraissy JF, Galanaud P.
    Eur J Immunol; 1986 Dec 01; 16(12):1503-7. PubMed ID: 3102243
    [Abstract] [Full Text] [Related]

  • 9. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT, Springgate CF, Piela TH, Choi YS.
    J Immunol; 1987 Apr 15; 138(8):2554-60. PubMed ID: 3031160
    [Abstract] [Full Text] [Related]

  • 10. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
    Saiki O, Shimizu M, Saeki Y, Kishimoto S, Kishimoto T.
    J Immunol; 1984 Oct 15; 133(4):1920-4. PubMed ID: 6088629
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the cell surface receptors for human B cell growth factor of 12,000 molecular weight.
    Mehta SR, Grant SR, Maizel AL.
    J Immunol; 1986 Oct 01; 137(7):2210-4. PubMed ID: 3093567
    [Abstract] [Full Text] [Related]

  • 12. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
    Romagnani S, Giudizi GM, Almerigogna F, Biagiotti R, Alessi A, Mingari C, Liang CM, Moretta L, Ricci M.
    Eur J Immunol; 1986 Jun 01; 16(6):623-9. PubMed ID: 3087756
    [Abstract] [Full Text] [Related]

  • 13. Activity of a partially purified human BCGF on murine assays for B cell stimulatory factors. II. Synergy between two distinct BCGF II-like factors in promoting B cell differentiation.
    Ennist DL, Elkins KL, Cheng SC, Howard M.
    J Immunol; 1987 Sep 01; 139(5):1525-31. PubMed ID: 2957428
    [Abstract] [Full Text] [Related]

  • 14. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S, Taguchi M, Watanabe Y, Okubo T, Murachi T, Uchino H, Hanaoka M.
    J Immunol; 1984 Dec 01; 133(6):3084-90. PubMed ID: 6238094
    [Abstract] [Full Text] [Related]

  • 15. Low molecular weight B cell growth factor-responsive cloned human B cell lines. I. Phenotypic differences and lack of requirement for CD23 (Fc epsilon RII).
    Warrington RJ, Rutherford WJ, Wong SK, Cook JM, Rector ES.
    J Immunol; 1989 Oct 15; 143(8):2546-52. PubMed ID: 2529311
    [Abstract] [Full Text] [Related]

  • 16. Synergy between B cell differentiation factors and interleukin 2, using a monoclonal system.
    Mayer L, Crow MK, Thompson C.
    J Immunol; 1985 Nov 15; 135(5):3272-6. PubMed ID: 2995489
    [Abstract] [Full Text] [Related]

  • 17. Human interferon-gamma acts as a B cell growth factor in the anti-IgM antibody co-stimulatory assay but has no direct B cell differentiation activity.
    Defrance T, Aubry JP, Vanbervliet B, Banchereau J.
    J Immunol; 1986 Dec 15; 137(12):3861-7. PubMed ID: 3097134
    [Abstract] [Full Text] [Related]

  • 18. Comparative activation requirements of human peripheral blood, spleen, and lymph node B cells.
    Jelinek DF, Lipsky PE.
    J Immunol; 1987 Aug 15; 139(4):1005-13. PubMed ID: 3112218
    [Abstract] [Full Text] [Related]

  • 19. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
    Kabelitz D, Pfeffer K, von Steldern D, Bartmann P, Brudler O, Nerl C, Wagner H.
    J Immunol; 1985 Oct 15; 135(4):2876-81. PubMed ID: 2993419
    [Abstract] [Full Text] [Related]

  • 20. B cell growth factor activity of immunoaffinity-purified and recombinant human interleukin 2.
    Mingari MC, Gerosa F, Moretta A, Zubler RH, Moretta L.
    Eur J Immunol; 1985 Feb 15; 15(2):193-6. PubMed ID: 3871701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.